Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA: Zofran 32-mg Dose Pulled From Market
The anti-nausea drug may cause serious heart problems at that dosage
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

December 18, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Sedatives Still Prescribed for Elderly Despite Risks

Over 50 FDA-Approved Meds Can Help Battle Ebola Infection

FDA: New System Targets Pathogens in Donated Blood Plasma

Digital Self-Scheduling Set to Increase Considerably by 2019

Internal Carotid Artery Tear Seen in Child After Roller-Coaster Ride

Hospital Staff Say 'Crisis Mode' Obstructs Communication